Trial intelligence / Profile preview

Inhaled salbutamol for pain relief in acute renal colic

IRCT20231205060266N1Phase 2Completed

Sponsor
Mazandaran University of Medical Sciences
Start
Apr 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, double-blind trial of salbutamol and ketorolac in Renal colic (2 arms), sponsored by Mazandaran University of Medical Sciences. Primary endpoints: Pain intensity and Hemodynamic index. Started Apr 2024; status: completed.

02

Drugs

salbutamolketorolac
03

Conditions

Renal colic

Beyond the preview

Go deeper on IRCT20231205060266N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20231205060266N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call